Literature DB >> 27491566

Pitfalls in lupus.

M Schneider1.   

Abstract

"The objective of Pitfall!™ is to guide Harry through a maze of jungle scenes, jumping over or avoiding many deadly dangers… Harry has three lives in each game." If you exchange Harry's adventures with "Life with SLE," patients have to be guided through the jungle having just one life and the deadly dangers are flares, organ manifestations, and, e.g., consequences of immunosuppressive medications, especially glucocorticoids. Monitoring and treatment in line with recommendations and guidelines may be supportive to survive the first 3 to 5 levels in most cases, but for higher levels of the reality game, creativity is needed and life becomes more risky. The aim of this reflection is to identify common pitfalls and to stimulate further research and collaboration in specific areas of the lupus jungle. Topics like "Hidden Power Unit," "Looks similar …," "Rev Meter for SLE," "Flare Prediction," "Level 2: Eminence Based," "Lupus=Lifelong Immunosuppression?!," "Glucocorticoids," "Antimalarials Are Contraindicated," "It Is All About Immunosuppression," "Prediction of Damage," and "Patient Global Assessment (PGA) versus Physician Global Assessment (PhGA)" are addressed. Raised ideas and thoughts are by no means complete or exclusive, but if taken up, they may hopefully lead to another approach in daily care and trials in SLE.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27491566     DOI: 10.1016/j.autrev.2016.07.033

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  3 in total

Review 1.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 2.  Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.

Authors:  Savino Sciascia; Massimo Radin; Jinoos Yazdany; Maria Tektonidou; Irene Cecchi; Dario Roccatello; Maria Dall'Era
Journal:  Rheumatol Int       Date:  2017-03-03       Impact factor: 2.631

3.  Frequency and Type of Hepatic and Gastrointestinal Involvement in Juvenile Systemic Lupus Erythematosus.

Authors:  Leila Tahernia; Hosein Alimadadi; Fatemeh Tahghighi; Zahra Amini; Vahid Ziaee
Journal:  Autoimmune Dis       Date:  2017-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.